Events
Network and get involved
Show Me
Coming Up
How to prepare for a due diligence review by investor, potential licensees, and buyers (with a little IP sprinkled in)
April 15, 2026
2:30 PM EDT
John W. Boger, Partner, Heslin Rothenberg Farley Mesiti
This presentation will outline the many steps that a company should take to best prepare for a corporate due diligence review from both the buyer/investor/licensee and seller/licensor perspective. The discussion will focus on how a company can proactively position itself to cover the many corporate areas that will be reviewed and investigated. From the seller perspective, the presentation will outline what a company can do to best present the value of its assets, including its intellectual property and research and development activities. From a buyer perspective, the discussion will focus on the critical corporate areas that require investigation to mitigate downstream risk post-transaction closure. A checklist that can be used as a guide when either preparing for or undertaking a due diligence review will be shared with all participants.
Virtual
NewYorkBIO x Egnyte Webinar
June 10, 2026
10:00 AM EDT
Are you ready for your next milestone? NewYorkBIO and Egnyte are co-hosting a webinar to map the journey from company founding through the clinical stage. We will explore what a scalable, compliant data foundation looks like at each milestone and highlight common pitfalls that slow growing biotechs down. The discussion will draw on real-world examples from companies incubated by Third Rock Ventures and other growth-stage biotechs, including Nimbus Therapeutics, Foghorn Therapeutics, and BridgeBio.
NYBIO Exclusive
Have a virtual or in-person conference, seminar, networking opportunity, or other event to promote?